CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program, antimicrobial resistance legislation, VICP Program, and PDUFA Reauthorization; Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22) implementation; S.920, The Affordable and Safe Prescription Drug Importation Act; S.3799, PREVENT Pandemics Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; S.2428, False Claims Amendments Act of 2021; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Implementation of Tax Cuts and Jobs Act (P.L.115-97). Issues related to R&D tax credit; FY2023 Consolidated Appropriations Act (H.R.2617).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical IP and supply chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Issues related to appropriations and federal health programs; reimbursement and vial size issues; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Consolidated Appropriations Act (H.R.2617).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.